Drawing for AMBAR

USPTO serial 88385978

AMBAR

Reviewed by CopyMark Law Group

Reg. 6197963Status 700Renewal
Filing date
Status date
Registration date
Nov 17, 2020
Examiner
KHAN, ASMAT A
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with AMBAR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,842*

Plus Government fees of $2,600

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ashly I. Boesche

Ashly I. Boesche PATTISHALL, MCAULIFFE, NEWBURY, HILLIARD200 S. WACKER DRIVE, SUITE 2900CHICAGO, IL 60606UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for Plasma Protein Replacement Therapies; Diagnostic preparations for medical purposes, namely, plasma-derived protein preparation for medical purposes; Biological preparations for use with Plasma Protein Replacement Therapies for the treatment of Alzheimer's disease and other cognitive disordersACTIVE—
009Computer programs and software recorded and downloadable for use in database management in the field of Plasma Protein Replacement Therapies; Electronic publications, both downloadable and recorded on computer media, in the nature of journals and reports from scientific congresses and clinical trial studies in the field of Plasma Protein Replacement TherapiesACTIVE—
010Medical apparatus and instruments, namely, medical apparatus and instruments for the treatment of Alzheimer's disease and other cognitive disordersACTIVE—
016Printed publications in the nature of journals, reports from scientific congresses, and educational and teaching materials in the field of Plasma Protein Replacement Therapies; Printed promotional materials, namely, pamphlets, brochures and reports from clinical trial studies in the field of medical treatments for Alzheimer's disease; Books in the field of Plasma Protein Replacement Therapies; Booklets in the field of Plasma Protein Replacement Therapies; Catalogues in the field of Plasma Protein Replacement Therapies; Diagrams for illustrating plasma protein replacement therapy; Printed flyers in the field of Plasma Protein Replacement Therapies; Printed forms; Graphic prints and graphic art reproductions and representations; Newsletters about Plasma Protein Replacement Therapies; PicturesACTIVE—
035Compilation of information into computer databases; Compilation of statistics; Computerized file management; Distribution of samples for publicity purposes; Document reproduction; Organization of exhibitions for commercial and advertising purposes; Organization of trade fairs for commercial and advertising purposes; Outdoor advertising; Radio and television advertising; Wholesale and retail store services in shops and on-line via global computer networks featuring pharmaceutical, biological and diagnostic preparations for medical purposes, computer programs and software recorded or downloadable, electronic publications, medical apparatus and instruments, printed publications, teaching materials, books, booklets, catalogues, diagrams, flyers, printed forms, graphic prints, reproduction and representations, newsletters and picturesACTIVE—
041Arranging and conducting educational colloquiums, conferences or congresses; Providing information about education; publication of on-line electronic books and journals; Practical training in the field of Plasma Protein Replacement Therapies; Publication of texts other than publicity texts; Arranging and conducting seminars, symposiums or workshops in the field of Plasma Protein Replacement Therapies; Teaching in the field of Plasma Protein Replacement Therapies; Educational services, namely, conducting classes, courses and workshops in the field Plasma Protein Replacement Therapies; Instruction services, namely, conducting classes, courses and workshops in the field of Plasma Protein Replacement TherapiesACTIVE—
042Biological research; conducting clinical trials for others; Rental of computer software; Electronic data storage; Installation and maintenance of computer software; Quality control of goods and services; Packaging design; Research and development of new products for others; Scientific laboratory services; Scientific research; Conducting feasibility studies in the field of new technologies for Plasma Protein Replacement Therapies; Technology consultation in the field of Plasma Protein Replacement TherapiesACTIVE—
044Healthcare; Convalescent home services; Hospital services; Medical clinic services; Medical assistance; Medical equipment rental; Nursing home services; Palliative care; Therapy services, namely, Plasma Protein Replacement; Services of a psychologistACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 17, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 17, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 1, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 1, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 12, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 21, 2020FIXDELECTRONIC RECORD REVIEW COMPLETE—
Jul 17, 2020ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Jul 11, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 11, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Jul 11, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 11, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 11, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 6, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Jul 6, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 6, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 6, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 16, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 16, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 15, 2020ALIEASSIGNED TO LIE—
Jun 10, 2020ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Jan 10, 2020GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jan 10, 2020GNSLLETTER OF SUSPENSION E-MAILED—
Jan 10, 2020CNSLSUSPENSION LETTER WRITTEN—
Jan 6, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Jan 6, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 6, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 6, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 12, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 12, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 10, 2019ALIEASSIGNED TO LIE—
Dec 2, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 1, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 1, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 1, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 29, 2019DOCKASSIGNED TO EXAMINER—
May 2, 2019MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
May 1, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 18, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance